Investigational Drug Information for Lysergic acid diethylamide
✉ Email this page to a colleague
What is the drug development status for Lysergic acid diethylamide?
Lysergic acid diethylamide is an investigational drug.
There have been 20 clinical trials for Lysergic acid diethylamide.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2008.
The most common disease conditions in clinical trials are Headache, Cluster Headache, and Caregiver Burden. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Eleusis Therapeutics, and Canisius-Wilhelmina Hospital.
Summary for Lysergic acid diethylamide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,139 |
| WIPO Patent Applications | 1,918 |
| Japanese Patent Applications | 999 |
| Clinical Trial Progress | Phase 2 (2008-02-01) |
| Vendors | 11 |
Recent Clinical Trials for Lysergic acid diethylamide
| Title | Sponsor | Phase |
|---|---|---|
| LSD Occupancy of the Serotonin 2A Receptor in the Human Brain | Rigshospitalet, Denmark | Early Phase 1 |
| Lysergic Acid Diethylamide (LSD) in Palliative Care | University Hospital, Zürich | Phase 2 |
| Lysergic Acid Diethylamide (LSD) in Palliative Care | University Hospital, Basel, Switzerland | Phase 2 |
Clinical Trial Summary for Lysergic acid diethylamide
Top disease conditions for Lysergic acid diethylamide
Top clinical trial sponsors for Lysergic acid diethylamide
US Patents for Lysergic acid diethylamide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
